NewsVandana Singh
Aurora Cannabis
ACB · TORONTO
$3.88−$0.09 (−2.27%)TodayMarket closed ·
Prev close $3.97
Latest news
- Press releasePRNewswire
Aurora Cannabis Reaffirms Recommendation to Shareholders: REJECT Curaleaf's Revised Hostile Bid; Preserve Opportunities for Future Upside
- Press releasePRNewswire
Aurora Completes Major Expansion of European EU-GMP Manufacturing Facility, More Than Doubling Expected Annual Flower Output
- Press releasePRNewswire
Aurora Urges Shareholders to Take No Action to Revised Hostile Bid by Curaleaf as Formal Review Underway
- Press releasePRNewswire
Aurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile Bid
- Press releasePRNewswire
Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure
- Press releasePRNewswire
Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and Beyond
- News
Curaleaf Pens Letter To Aurora Cannabis Shareholders Urging Acceptance Of Its Takeover Offer
- Press releasePRNewswire
Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From The Facts
- Press releasePRNewswire
Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business
- NewsVandana Singh
Aurora Cannabis Fires Back at Curaleaf’s Hostile Takeover Bid
- Press releasePRNewswire
Curaleaf Responds to Aurora Circular; Reaffirms Offer as the Best Path to Value Creation for Shareholders
- Press releasePRNewswire
Aurora Cannabis Urges Shareholders to REJECT Curaleaf's Hostile Bid, Warning that it is Inadequate, Undervalues Aurora and Puts Shareholder Value and Future Upside at Risk
- Press releasePRNewswire
Curaleaf Responds to Aurora Cannabis' Latest Attempt to Deflect From Shareholder Value Creation
- Press releasePRNewswire
AURORA CANNABIS CORRECTS INACCURATE STATEMENTS MADE IN SUPPORT OF CURALEAF HOLDINGS' HOSTILE BID
- Press releasePRNewswire
Aurora Cannabis Furthers Global Medical Cannabis Growth with Accretive Acquisition of Internode Pharma Limited and HAP Pharma Limited, Expanding Distribution Access to the UK Medical Cannabis Market
- Press releasePRNewswire
AURORA CANNABIS INC. URGES SHAREHOLDERS TO TAKE NO ACTION AT THIS TIME IN RESPECT TO THE UNSOLICITED TAKE-OVER BID BY CURALEAF HOLDINGS, INC.
- Press releasePRNewswire
AURORA CANNABIS INC. RESPONDS TO PRESS RELEASE OF CURALEAF HOLDINGS, INC. REGARDING INTENTION TO LAUNCH UNSOLICITED TAKE-OVER BID
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- NewsVandana Singh
Curaleaf Goes Public with Premium Acquisition Proposal for Aurora Cannabis
- Press releasePRNewswire
Curaleaf Announces Intention to Launch Take-Over Bid for Aurora Cannabis to Solidify its Position as the Global Cannabis Industry Leader
- Press releasePRNewswire
Aurora, a Global Leader in Medical Cannabis, Announces Results of 2026 Annual General Meeting
- Press releasePRNewswire
Aurora Cannabis Announces Fiscal 2027 First Quarter Results
- Press releasePRNewswire
Aurora Receives Support from Leading Independent Proxy Adviser Institutional Shareholder Services Inc. for the 2026 Annual General Meeting of Shareholders
- Press releasePRNewswire
Safari Flower Company, a Wholly Owned Subsidiary of Aurora Cannabis, Receives EU-GMP Certification at Niagara Facility
- Press releasePRNewswire
Aurora Cannabis to Host First Quarter 2027 Investor Conference Call
- Press releasePRNewswire
Aurora Named to TIME Canada's Best Companies 2026 List
- Press releasePRNewswire
Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders
- News
Full Transcript: Aurora Cannabis Q4 2026 Earnings Call
- News
Earnings Scheduled For June 11, 2026
- Press releasePRNewswire
Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quarter Results with Record Annual Revenue and Adjusted EBITDA¹
- Press releasePRNewswire
Aurora Deepens its Impact for Veterans Across Canada
- News
Aurora Cannabis Q3 Earnings Summary & Key Takeaways
- News
Aurora Cannabis Earnings Review: Q3 Summary
- News
Aurora Cannabis: Q3 Earnings Insights
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.